Onderneming Miragen Therapeutics Inc Nasdaq
Aandelen
US8266402036
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
11/06 | Sectorupdate: Gezondheidszorgaandelen dinsdag premarket gemengd | MT |
11/06 | Sectorupdate: Gezondheidszorg | MT |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monoclonal Antibody
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -82,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 0 | 100,0 % | -82,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Seth Harmon
DFI | Director of Finance/CFO | 45 | 01-05-23 |
Thomas Ciulla
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-01-23 |
Thomas Beetham
COO | Chief Operating Officer | 55 | 30-10-23 |
Angela Sheen
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Shan Wu
PRN | Corporate Officer/Principal | - | 30-10-23 |
Vahe Bedian
PRN | Corporate Officer/Principal | - | 28-10-20 |
Anthony Casciano
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arlene Morris
BRD | Director/Board Member | 72 | 03-01-18 |
Tomas Kiselak
CHM | Chairman | 37 | 28-10-20 |
Stephen Mahoney
CEO | Chief Executive Officer | 53 | 30-10-23 |
Peter Harwin
BRD | Director/Board Member | 38 | 28-10-20 |
Jennifer Moses
BRD | Director/Board Member | 49 | 14-07-21 |
Sarah Gheuens
BRD | Director/Board Member | 45 | 25-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 157 435 | 0 | 0 | 94,26 % |
Aandeel B | 0 | 143 522 | 0 | 0 | |
Aandeel C | 1 | 63 822 468 | 60 160 266 ( 94,26 %) | 0 |
Bedrijfsgegevens
Viridian Therapeutics, Inc.
221 Crescent Street Suite 401
02453, Waltham
+
http://www.viridiantherapeutics.com![Adres Miragen Therapeutics Inc](https://cdn.zonebourse.com/static/address/31827827.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,74% | 46,56 mld. | |
+45,38% | 41,67 mld. | |
+0,19% | 41,16 mld. | |
+33,00% | 32,4 mld. | |
+21,08% | 28,18 mld. | |
-6,35% | 28,1 mld. | |
+48,92% | 14,52 mld. | |
+47,49% | 13,74 mld. | |
+3,04% | 12,17 mld. |
- Beurs
- Aandelen
- Koers VRDN
- Koers
- Onderneming Miragen Therapeutics Inc